Allergan's Botox still a physician favorite for migraine despite CGRP push: analyst

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 21, 2020 at 11:22 AM.

  1. #1 cafead, Feb 21, 2020 at 11:22 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via With CGRP drugs on the rise in the preventive migraine market, old stalwarts like Allergan's Botox are feeling the pinch from the new competition. But a new survey says neurologists may not be so quick to give up on Botox––and that could be another win for AbbVie on the eve of its Allergan merger.

    article source
     
    Quote

Reply to Thread